Skip to main content
Loading...
Menu social network
LinkedIn
Facebook
X
Youtube
Menu top
Assistance
User account menu
Log in
Main navigation
Home
Programme
Download the app
App
Download the app
App
Menu
Login
Close
Main navigation mobile
Home
Programme
Menu top
Assistance
Menu social network
LinkedIn
Facebook
X
Youtube
21 results
D1.19 - Etoricoxib-Induced Fixed Drug Eruption: A Case Series and Assessment of Tolerance to Alternative NSAIDs
D1.18 - Not Just for Kids: A Rare Case of Adult-Onset IgE-Mediated Cow’s Milk Allergy Masquerading as Drug Hypersensitivity
D1.20 - Challenges in Safe Alternative Selection in a Case of Amoxicillin-Induced Anaphylaxis
D1.21 - Three cases of Food induced Anaphylaxis - Role of Cofactors
D1.25 - Cannabis-Fruit-Veggie Syndrome: From Respiratory Symptoms to Life-Threatening Anaphylaxis
D1.26 - Egg Allergy Persistence Beyond 8 Years of Age
D1.28 - Clinical Follow-up in Radiocontrast Media–Induced Hypersensitivity Reactions: Beyond the Reaction
D1.29 - When Anaphylaxis Is Not Anaphylaxis: A Rare Differential Diagnosis in Perioperative Shock
D1.30 - Allergy Care in Adult Cystic Fibrosis Patients with Drug Hypersensitivity: A Service Evaluation at St Bartholomew’s Hospital
D1.31 - Identification of Process-Modified Allergens in Tiger Nut Milk (Horchata) as the Cause of IgE-Mediated Anaphylaxis: Molecular Evidence of Aldolase and α/β-Hydrolase Proteins
D1.123 - Visualization of neutrophil extracellular traps (NETs) and autoantibodies targeting myeloperoxidase (MPO) and neutrophil elastase (NE) in sputum by confocal microscopy
D1.124 - Changes in respiratory infections patterns in Patients with Severe Asthma and a High burden of comorbidities treated with tezepelumab: interim analysis results of the T-ROSS II study
D1.126 - Therapeutic Splenic Ultrasound Insonation as a Modulator of Pro-atherogenic and Pro-asthmatic Immune Inflammation: A Preclinical Study Design
D1.128 - Use of Tezepelumab in four Patients with Allergic Bronchopulmonary Aspergillosis and severe uncontrolled Asthma: A Case Series
D1.130 - Immune markers after one year treatment with benralizumab in severe eosinophilic asthma
D1.131 - Unconventional Group 2 Innate Lymphoid Cells Expressing C-Kit and IL-17A are Increased in Sputum from Severe Asthma with Mixed Granulocytic Airway Inflammation
D2.19 - Can Drug Provocation Be Avoided in Low-Risk Quinolone Reactions?
D2.17 - Diagnostic profitability of penicilloyl-polylysine and minor determinant mixture in urgent/preferred beta-lactam allergy studies in hospitalized patients from january 2023 to december 2025
D2.20 - Selective Fixed Drug Eruption from Etoricoxib with Safe Celecoxib Use: Role of Patch Testing
D2.21 - The Cyto-LTT: A multiplex cytokine assay to detect and assess the strength of T cell reactivity in drug hypersensitivity
Pagination
Current page
1
Page
2
Next page
Next
Last page
Last
Download the app
The congress at your fingertips
Available on
Download